Video Experimental Relacionado
Updated: Aug 16, 2026
07:02
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 15, 2010
Efectos antirretrovirales del interferón alfa en el sarcoma de Kaposi asociado al SIDA
H C Lane1, J A Kovacs, J Feinberg
1Laboratory of Immunoregulation and Treatment Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
Lancet (London, England)
|November 26, 1988
Resumen
El interferón alfa recombinante (IFN-alfa) mostró beneficios antitumorales y antirretrovirales en pacientes con SIDA y sarcoma de Kaposi. El tratamiento en etapa temprana con IFN-alfa fue más efectivo en pacientes con recuentos de CD4 más altos.
Área de la Ciencia:
- Oncología Oncología.
- Virología Virología.
- Inmunología Inmunología.
Sus antecedentes:
- El sarcoma de Kaposi es un cáncer que define el SIDA.
- La infección por el virus de la inmunodeficiencia humana (VIH) conduce a la supresión inmunológica.
- El interferón alfa (IFN-alfa) está siendo investigado por su potencial terapéutico en el VIH/SIDA.
Objetivo del estudio:
- Para evaluar la actividad antirretroviral in vivo del interferón alfa recombinante (IFN-alfa).
- Para evaluar la respuesta antitumoral en pacientes con SIDA y sarcoma de Kaposi tratados con IFN-alfa.
Principales métodos:
- Se realizó un ensayo terapéutico abierto con 21 pacientes diagnosticados con SIDA y sarcoma de Kaposi.
- Los pacientes recibieron tratamiento con interferón alfa recombinante (IFN-alfa).
- La respuesta tumoral y los marcadores de carga viral (HIV p24) fueron monitoreados, junto con el recuento de células T CD4 +.
Principales resultados:
- Se observó una respuesta antitumoral completa o parcial en 8 de los 21 pacientes (38%).
- Los que respondieron tuvieron un recuento medio de CD4 antes del tratamiento significativamente más alto (399 células/μL) en comparación con los que no respondieron (154 células/μL).
- Los pacientes con recuentos de CD4 más altos (>400 células / μL) mostraron una reducción significativa del tumor, mientras que aquellos con recuentos más bajos (<150 células / μL) no mostraron respuesta. Los efectos antivirales, incluidos los niveles reducidos de p24 del VIH y los cultivos negativos de VIH, fueron más pronunciados en pacientes con recuentos de CD4 más altos.
Conclusiones:
- El interferón alfa recombinante (IFN-alfa) demuestra beneficios tanto antitumorales como antirretrovirales en pacientes con VIH y sarcoma de Kaposi.
- El tratamiento con IFN-alfa parece ser más beneficioso en las primeras etapas de la infección por VIH y el sarcoma de Kaposi, particularmente en pacientes con recuentos más altos de células T CD4 +.
- La terapia con IFN-alfa puede conducir a reducciones significativas en la carga viral y la carga tumoral, lo que sugiere su potencial como una opción terapéutica.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...